Lung Cancer Screening Software Market Advanced Technology, Future Opportunities And Forecast To 2025

07/nov/2019 11:46:11 Market Research News Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

The global lung cancer screening software market size is estimated to reach USD 37.92 million by 2025 expanding at a CAGR of 19.5% from 2019 to 2025, according to a new report by Grand View Research, Inc. Growing incidence of lung cancer and rise in implementation of lung cancer screening programs across the globe are some of the significant factors driving the market growth. According to Globocan estimates, about 160,068 new cases of lung cancer were reported in South East Asian region in 2018.

A number of clinical trials, studies, and demonstration projects are being conducted around the world to evaluate the effectiveness of lung cancer screening programs. For instance, in 2017, Cancer Care Ontario launched a screening pilot trial for people at high risk. Favorable government initiatives for successful implementation of such programs and increasing awareness about the disease screening are also likely to contribute to the market growth in the coming years.

lung Cancer

Lung cancer screening programs are widely adopted by hospitals and radiological centers in U.S. However, they are usually performed as a part of national or provisional screening program outside the country. In case of Latin America and Middle Eastern countries, limited availability of resources, restricted funding, low awareness levels, and lack of trained personnel are some of the factors that impede market growth.

Access Research Report of Lung Cancer Screening Software Market @

Further key findings from the study suggest:

  • In 2018, North America accounted for the highest revenue share owing to various lung cancer screening programs and favorable reimbursement scenario in the region
  • Asia Pacific is expected to be the fastest-growing regional market over the forecast period
  • This is attributed to the increasing cases of lung cancer and rise in the number of screening trials & studies for the disease
  • Nuance Communications, Inc.; Eon; Koninklijke Philips N.V.; Siemens Healthineers AG; PenRad Technologies, Inc.; MRS Systems, Inc.; and Magview are some of the key companies in the market

Grand View Research has segmented the global lung cancer screening software market on the basis of region:

Lung Cancer Screening Software Regional Outlook (Revenue, USD Thousand, 2014 - 2025)

  • North America
    • US.
    • Canada 
  • Europe
    • UK.
    • Germany
    • Italy
    • France
    • Spain
    • Russia 
  • Asia Pacific
    • Japan
    • China
    • Australia 
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa

Access Press Release of Lung Cancer Screening Software Market@

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


For More Information:

blog comments powered by Disqus è un servizio offerto da Factotum Srl